MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2019 International Congress

    Social Cognition, Neuropsychological functioning & Mood Disorder in Cervical Dystonia (CD)

    R. Monaghan, D. Mccormack, I. Ndukwe, T. Burke, N. Pender, S. O’Riordan, M. Hutchinson, F. O'Keeffe (Dublin, Ireland)

    Objective: This study investigated social cognition, neuropsychological functioning and mood disorder in CD. Background: CD is a hyperkinetic movement disorder of unknown cause. Although historically…
  • 2019 International Congress

    Electroconvulsive Therapy (ECT): An Effective Option for the Treatment of Medication-Resistant Psychiatric Symptoms in Huntington’s Disease: A Case Series and Review of the Literature

    J. Adrissi, N. Nadkarni, E. Gausche, D. Bega (Chicago, IL, USA)

    Objective: Through a single site case series, we investigate the use and effectiveness of electroconvulsive therapy (ECT) for the treatment of refractory psychiatric symptoms in…
  • 2019 International Congress

    Identifying the association of depression and distress in Pakistani patients diagnosed with Parkinsonism syndrome

    A. Fatima (Lahore, Pakistan)

    Objective: Our study aims to identify depression and distress among Pakistani patients diagnosed with Parkinsonism syndrome. We also aim to find out the relationship among depression, distress caused Parkinsonism syndrome.…
  • 2019 International Congress

    Trust the Patient’s Report, not the Doctor’s: Non-Motor Symptoms and Quality of Life in Cervical Dystonia

    I. Ndukwe, J. Dover, P. Lynch, C. O'Neill, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To assess the prevalence of mood disorder and measure health-related quality of life (Hr-QoL) in relation to, pain, disability and disease severity in cervical…
  • 2019 International Congress

    Gene Expression Profiling of depression in Huntington’s disease

    G. Colpo, N. Rocha, E. Furr Stimming, A. Lucio (Houston, TX, USA)

    Objective: This preliminary study was designed to investigate the gene expression profile by RNA-seq in HD patients with depression and without depression, and between subjects…
  • 2019 International Congress

    Predictors of Health-Related Quality of Life in Patients with Cervical Dystonia

    SA. Reijneveld, Z. Gdovinova, MAJ. Tijssen, JP. van Dijk, T. Hoekstra, M. Turcanova Koprusakova, M. Smit, M. Skorvanek, V. Han (Martin, Slovakia)

    Objective: The aim of our study was to assess the prevalence of non-motor symptoms (NMS) and to explore their association with health-related quality of life…
  • 2019 International Congress

    Deep phenotyping adult onset isolated cervical dystonia; the importance of symptomatic anxiety and depression.

    I. Ndukwe, J. Dover, P. Lynch, F. O'Keeffe, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: Objective:We aimed to characterise the demographic and clinical aspects of cervical dystonia (CD) patients with symptomatic anxiety and depression. We hypothesised that these patients…
  • 2019 International Congress

    Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson’s disease.

    M. Meloni, M. Puligheddu, M. Carta, M. Figorilli, G. Defazio (Cagliari, Italy)

    Objective: The purpose of this study was to compare the effects of 5-HTP to placebo on depression and apathy in patients with PD. Background: Parkinson’s…
  • 2019 International Congress

    Gender differences in Motor symptoms, Non-Motor symptoms and Quality of Life in Parkinson’s disease: COPPADIS-2015 study cohort

    M. Aguilar, P. Pastor, B. Solano, I. Cabo, MJ. Catalan, V. Nogueira, V. Puente, JM. Garcia, R. Perez, C. Borrué, M. Mata, M. Alvarez, AB. Rodriguez, L. Vela, Y. Macías, MJ. Marti, P. Martinez, D. Santos (Sabadell, Spain)

    Objective: To assess gender differences among PD patients and health controls (HC) of the COPPADIS-2015 study cohort. Background: Men and women are different in genetic,…
  • 2019 International Congress

    The effect of istradefylline on mood disorders in Parkinson’s disease

    H. Nagayama, O. Kano, H. Murakami, M. Hamada, R. Sengoku, Y. Shim, T. Toda (Tokyo, Japan)

    Objective: The effectiveness of istradefylline for treatment of mood disorders in patients with Parkinson's disease (PD) was examined in an open-label trial. Background: Depression is…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 38
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley